NSL literature pointer PMID 38996787 Ipamorelin laboratory index [PMID: 38996787] National Science Labs indexing note for PMID 38996787: review the PubMed methods, models, and limitations before citing
For patients who are not well-controlled on a treatment with metformin and basal insulin, a treatment intensification with a DPP-4 inhibitor may be feasible
Pola P, Tondi P, Dal Lago A, and et al
PubMed Duzel, A., Vlainic, J., Antunovic, M., Malekinusic, D., Vrdoljak, B., Samara, M., Gojkovic, S., Krezic, I., Vidovic, T., Bilic, Z., Sjekavica, I., Djuzel, A.R., Knezevic, M., Sever, A.Z., Lojo, N., Kokot, A., Sever, M., Drmic, D., Seiwerth, S., & Sikiric, P
First, it has direct anti-inflammatory effects, addressing pain at its source rather than simply masking symptoms
(4) Sackmann-Sala L, Ding J, Frohman LA, Kopchick JJ